Analyst consensus rating
Chemed Analyst Rating: none
CHE is rated none by 4 analysts with a $552.00 target. As of 2026-08-19.
Direct answer
Chemed's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $552.00.
Forecast evidence checked August 19, 2026.
Get free Chemed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $535.70
- Average price target
- $552.00
- High price target
- $590.00
- Low price target
- $520.00
- Low target gap
- -2.9%
- Target upside
- +3%
- High target gap
- +10.1%
- Target range width
- 13.1%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Chemed?
Chemed has a verified none consensus. The same dataset has an average price target of $552.00.
How far are Chemed's low and high targets from the recorded price?
The low target implies -2.9%, while the high target implies +10.1%.
How many analysts are included in Chemed's consensus?
The verified consensus includes 4 analysts.
How is Chemed's target upside or downside calculated?
The average target of $552.00 is divided by the recorded price of $535.70, then one is subtracted to produce +3%. This does not guarantee a future return.
When was Chemed's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.